Trial intelligence / Profile preview

Adjunctive clindamycin for cellulitis (C4C)

ISRCTN86329346Phase 4Completed

Sponsor
University Hospitals Bristol and Weston NHS Foundation Trust
Start
Oct 2013
Modality
Small Molecules
01

Overview

Phase 4, randomised, double-blind trial of clindamycin and flucloxacillin in cellulitis (2 arms), sponsored by University Hospitals Bristol and Weston NHS Foundation Trust. Primary endpoint: Improvement of systemic and local features at Day 5. Started Oct 2013; status: completed.

02

Drugs

clindamycinflucloxacillin
03

Conditions

cellulitis

Beyond the preview

Go deeper on ISRCTN86329346.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ISRCTN86329346.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call